These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 26524379)
1. First-in-Class Inhibitors of Sulfur Metabolism with Bactericidal Activity against Non-Replicating M. tuberculosis. Palde PB; Bhaskar A; Pedró Rosa LE; Madoux F; Chase P; Gupta V; Spicer T; Scampavia L; Singh A; Carroll KS ACS Chem Biol; 2016 Jan; 11(1):172-84. PubMed ID: 26524379 [TBL] [Abstract][Full Text] [Related]
2. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. Tomioka H Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755 [TBL] [Abstract][Full Text] [Related]
3. Structure-based virtual screening and biological evaluation of Mycobacterium tuberculosis adenosine 5'-phosphosulfate reductase inhibitors. Cosconati S; Hong JA; Novellino E; Carroll KS; Goodsell DS; Olson AJ J Med Chem; 2008 Nov; 51(21):6627-30. PubMed ID: 18855373 [TBL] [Abstract][Full Text] [Related]
4. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494 [TBL] [Abstract][Full Text] [Related]
5. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase. Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857 [TBL] [Abstract][Full Text] [Related]
6. A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum. Sarathy JP; Xie M; Jones RM; Chang A; Osiecki P; Weiner D; Tsao WS; Dougher M; Blanc L; Fotouhi N; Via LE; Barry CE; De Vlaminck I; Sherman DR; Dartois VA mBio; 2023 Apr; 14(2):e0059823. PubMed ID: 37017524 [TBL] [Abstract][Full Text] [Related]
7. Screening of Antitubercular Compound Library Identifies Inhibitors of Mur Enzymes in Eniyan K; Rani J; Ramachandran S; Bhat R; Khan IA; Bajpai U SLAS Discov; 2020 Jan; 25(1):70-78. PubMed ID: 31597510 [TBL] [Abstract][Full Text] [Related]
8. A high-throughput target-based screening approach for the identification and assessment of Smiejkowska N; Oorts L; Van Calster K; De Vooght L; Geens R; Mattelaer H-P; Augustyns K; Strelkov SV; Lamprecht D; Temmerman K; Sterckx YG-J; Cappoen D; Cos P Microbiol Spectr; 2024 Mar; 12(3):e0372323. PubMed ID: 38315026 [TBL] [Abstract][Full Text] [Related]
11. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach. Uddin R; Zahra NU; Azam SS Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161 [TBL] [Abstract][Full Text] [Related]
12. In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against Venugopala KN; Tratrat C; Pillay M; Chandrashekharappa S; Al-Attraqchi OHA; Aldhubiab BE; Attimarad M; Alwassil OI; Nair AB; Sreeharsha N; Venugopala R; Morsy MA; Haroun M; Kumalo HM; Odhav B; Mlisana K Drug Des Devel Ther; 2020; 14():1027-1039. PubMed ID: 32214795 [TBL] [Abstract][Full Text] [Related]
13. Discovery of the disubstituted oxazole analogues as a novel class anti-tuberculotic agents against MDR- and XDR-MTB. Li D; Gao N; Zhu N; Lin Y; Li Y; Chen M; You X; Lu Y; Wan K; Jiang JD; Jiang W; Si S Bioorg Med Chem Lett; 2015 Nov; 25(22):5178-81. PubMed ID: 26459210 [TBL] [Abstract][Full Text] [Related]
14. Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in Eoh H; Liu R; Lim J; Lee JJ; Sell P Front Cell Infect Microbiol; 2022; 12():958240. PubMed ID: 36072228 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents. Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612 [TBL] [Abstract][Full Text] [Related]
16. Target Discovery for New Antitubercular Drugs Using a Large Dataset of Growth Inhibitors from PubChem. Goldman RC Infect Disord Drug Targets; 2020; 20(3):352-366. PubMed ID: 30520384 [TBL] [Abstract][Full Text] [Related]
17. Targeting redox heterogeneity to counteract drug tolerance in replicating Mishra R; Kohli S; Malhotra N; Bandyopadhyay P; Mehta M; Munshi M; Adiga V; Ahuja VK; Shandil RK; Rajmani RS; Seshasayee ASN; Singh A Sci Transl Med; 2019 Nov; 11(518):. PubMed ID: 31723039 [TBL] [Abstract][Full Text] [Related]
18. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase. Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243 [TBL] [Abstract][Full Text] [Related]
19. Osmium-arene complexes with high potency towards Mycobacterium tuberculosis. Coverdale JPC; Guy CS; Bridgewater HE; Needham RJ; Fullam E; Sadler PJ Metallomics; 2021 Apr; 13(4):. PubMed ID: 33693931 [TBL] [Abstract][Full Text] [Related]
20. Discovery and optimization of benzotriazine di-N-oxides targeting replicating and nonreplicating Mycobacterium tuberculosis. Chopra S; Koolpe GA; Tambo-Ong AA; Matsuyama KN; Ryan KJ; Tran TB; Doppalapudi RS; Riccio ES; Iyer LV; Green CE; Wan B; Franzblau SG; Madrid PB J Med Chem; 2012 Jul; 55(13):6047-60. PubMed ID: 22691154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]